TrialScience progress

Effects of nebulized hypertonic saline on inflammatory mediators in patients with severe COVID-19 pneumonia: A double-blinded randomized controlled trial.

Mohammad-Taghi Beigmohammadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.